Flourish Research Acquires Merritt Island Medical Research
December 15, 2023
Flourish Research, a multi‑site clinical research platform backed by NMS Capital, has acquired Merritt Island Medical Research (MIMR) in Merritt Island, Florida. The deal is an add‑on to Flourish's platform (its tenth acquisition) and strengthens its neuroscience clinical research capabilities; MIMR's founders and leadership will remain with the site.
- Buyers
- Flourish Research, NMS Capital
- Targets
- Merritt Island Medical Research
- Platforms
- Flourish Research
- Industry
- Healthcare Services
- Location
- Florida, United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
NMS-backed Flourish Research Recapitalizes Great Lakes Clinical Trials and Clinical Site Partners
January 12, 2022
Healthcare Services
NMS Capital portfolio company Flourish Research completed recapitalizations of Great Lakes Clinical Trials and Clinical Site Partners, expanding its multi-site clinical trial network across Illinois, Florida and Texas. The deals (terms undisclosed) add site capacity and management teams to Flourish Research as the platform pursues network consolidation, improved operational efficiencies and accelerated growth.
-
Flourish Research (NMS Capital-backed) Acquires Valley Clinical Trials
September 15, 2023
Healthcare Services
NMS Capital–backed Flourish Research has acquired Valley Clinical Trials, a three-site clinical research organization in Los Angeles County focused on cardiology, metabolic and related therapeutic areas. The deal — Flourish’s ninth acquisition since 2021 — expands the platform’s West Coast footprint; terms were not disclosed and Valley’s founder and management will remain in their roles.
-
Flourish Research Acquires Suncoast Research Group
December 22, 2022
Healthcare Services
Flourish Research, an NMS Capital portfolio company, has acquired Suncoast Research Group, a multi-therapeutic clinical research site based in the Little Havana neighborhood of Miami, Florida. The founders and current management will remain in place; terms were not disclosed. The deal expands Flourish's integrated clinical site network and increases access to diverse patient populations in the Florida market.
-
Flourish Research / NMS Capital Recapitalize Excel Medical Clinical Trials
October 14, 2021
Healthcare Services
NMS Capital portfolio company Flourish Research partnered with Excel Medical Clinical Trials in a recapitalization. The Boca Raton, Florida-based clinical research site, founded by Dr. Seth Baum and focused on cardiology indications, will join Flourish's site network to expand the platform's geographic footprint and therapeutic capabilities; terms were not disclosed and management will remain in place.
-
Flourish Research Acquires ENCORE Research Group
June 25, 2024
Healthcare Services
NMS Capital portfolio company Flourish Research has partnered with ENCORE Research Group, a clinical research organization with eight locations across Northern Florida and more than 100 investigators. The transaction — the eleventh add-on to the Flourish platform since 2021 — expands Flourish's geographic footprint and therapeutic capabilities; terms were not disclosed.
-
Flourish Research (NMS Capital) Recapitalizes AMC Research and Central Research Associates
May 18, 2023
Healthcare Services
NMS Capital portfolio company Flourish Research partnered with company management to recapitalize AMC Research, LLC (Charlotte, NC) and Central Research Associates (Birmingham, AL). The transactions expand Flourish’s clinical research site network—augmenting its Alzheimer’s capabilities and adding scale in cardiology/metabolic/renal, vaccine and other therapeutic areas; terms were not disclosed.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.